231 related articles for article (PubMed ID: 26586647)
1. A review of the use of ethionamide and prothionamide in childhood tuberculosis.
Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2016 Mar; 97():126-36. PubMed ID: 26586647
[TBL] [Abstract][Full Text] [Related]
2. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis.
Hicks ND; Carey AF; Yang J; Zhao Y; Fortune SM
mBio; 2019 Apr; 10(2):. PubMed ID: 31015328
[TBL] [Abstract][Full Text] [Related]
4. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
5. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
[TBL] [Abstract][Full Text] [Related]
6. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
7. Activation of the pro-drug ethionamide is regulated in mycobacteria.
Baulard AR; Betts JC; Engohang-Ndong J; Quan S; McAdam RA; Brennan PJ; Locht C; Besra GS
J Biol Chem; 2000 Sep; 275(36):28326-31. PubMed ID: 10869356
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ethionamide in children.
Thee S; Seifart HI; Rosenkranz B; Hesseling AC; Magdorf K; Donald PR; Schaaf HS
Antimicrob Agents Chemother; 2011 Oct; 55(10):4594-600. PubMed ID: 21788468
[TBL] [Abstract][Full Text] [Related]
9. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
10. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
[TBL] [Abstract][Full Text] [Related]
11. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
[TBL] [Abstract][Full Text] [Related]
12. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the antituberculosis drug ethionamide.
Vale N; Gomes P; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):151-8. PubMed ID: 23215813
[TBL] [Abstract][Full Text] [Related]
14. Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in
Cao B; Mijiti X; Deng LL; Wang Q; Yu JJ; Anwaierjiang A; Qian C; Li M; Fang DA; Jiang Y; Zhao LL; Zhao X; Wan K; Liu H; Li G; Yuan X
Infect Drug Resist; 2023; 16():3117-3135. PubMed ID: 37228658
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates.
da Silva DA; Ferreira NV; Rego AM; Barbosa PCP; Machado RF; Pimentel A; Dos Reis LM; de Pina LC; Redner P; Caldas PCS; Fandinho-Montes FCO; Borga L; Leite SP; da Rocha JL; Bastos LS; Ramos JP; Degrave WM; Antunes LCM; Galvão TC
Tuberculosis (Edinb); 2018 Dec; 113():163-174. PubMed ID: 30514498
[TBL] [Abstract][Full Text] [Related]
16. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of thioamide drug action against tuberculosis and leprosy.
Wang F; Langley R; Gulten G; Dover LG; Besra GS; Jacobs WR; Sacchettini JC
J Exp Med; 2007 Jan; 204(1):73-8. PubMed ID: 17227913
[TBL] [Abstract][Full Text] [Related]
19. Can inhA mutation predict ethionamide resistance?
Vadwai V; Ajbani K; Jose M; Vineeth VP; Nikam C; Deshmukh M; Shetty A; Soman R; Rodrigues C
Int J Tuberc Lung Dis; 2013 Jan; 17(1):129-30. PubMed ID: 23146620
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.
Lee HW; Kim DW; Park JH; Kim SD; Lim MS; Phapale PB; Kim EH; Park SK; Yoon YR
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
